Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Pechala's Reports
$25.00
Provider: New Constructs, LLC
$25.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Carefusion Corp Lowers FY 2013 Revenue Guidance; Reiterates FY 2013 EPS Guidance


Thursday, 9 May 2013 04:02pm EDT 

Carefusion Corp announced that for fiscal 2013, it expects revenue to be flat to down low-single-digits on a percentage basis compared to fiscal 2012 revenue of $3.6 billion. The Company previously expected revenue to grow 1 to 3% on a constant currency basis. The Company reiterated its fiscal 2013 guidance range for adjusted diluted earnings per share (EPS) from continuing operations of $2.11 to $2.21. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $3.7 billion, EPS of $2.15 for fiscal 2013.